Clarithromycin Resistance Prevalence and Icea Gene Status in Helicobacter Pylori Clinical Isolates in Turkish Patients with Duodenal Ulcer and Functional Dyspepsia
![]() ![]() |
Baglan Peren H.
(Institute of Hepatology, Ankara University)
Bozdayi Gulendam (Department of Clinical Microbiology, Gazi University) Ozkan Muhip (Biometry Genetics Department, Agriculture Faculty, Ankara University) Ahmed Kamruddin (Department of Molecular Biology and Genetics, Bilkent University, Division of Molecular Epidemiology, Nagasaki University School of Medicine) Bozdayi A. Mithat (Institute of Hepatology, Ankara University, Department of Gastroenterology, School of Medicine, Ankara University) Ozden Ali (Department of Gastroenterology, School of Medicine, Ankara University) |
1 | Bayerdorffer, E., A. Neubauer, B. Rudolph, C. Thiede, N. Lehn, S. Eidt, and M. Stolte. 1995. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345, 1591-1594 DOI ScienceOn |
2 | Broutet, N., S. Tchamgoue, E. Pereira, H. Lamouliatte, R. Salamon, and F. Megraud. 2003. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment. Pharmacol. Ther. 17, 99-109 DOI ScienceOn |
3 | Ende, A, L.J. Doorn, S. Rooijakkers, M. Feller, G.N.J. Tytgat, and J. Dankert. 2001. Clarithromycin- susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastic biopsy specimens prior to antibiotic therapy. J. Clin. Microbiol. 39, 2648-2651 DOI ScienceOn |
4 | Goldman, R.C., D. Zakula, R. Flamm, I. Beyer, and I. Capobianco. 1994. Tight binding of clarithromycin, its 14- (R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob. Agents Chemother. 38, 1496- 1500 DOI ScienceOn |
5 | Lui, S.Y., K.G. Yeoh, and B. Ho. 2003. Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population. J. Clin. Microbiol. 41, 5011- 5014 DOI |
6 | Megraud, F., C. Camou-Juncas, A. Occhialini, and C. Birac. 1996. Helicobacter pylori resistance levels to clarithromycin remain stable. Gastroenterology 100, A192 |
7 | Megraud, F. 2004. Helicobacter pylori resistance: prevalence importance and advances in testing. Gut 53, 1374-1384 DOI ScienceOn |
8 | Palabiyikoglu, M., F. Sahin, A. Ozden, and O. Uzunalimoglu. 1997. Determination of primary resistance in Helicobacter pylori isolates to clarithromycin and amoxycilline by disc diffusion method and the comparison with resistance in recurrent cases. Turk. J. Gastroenterol. 8, 309-312 |
9 | Ribeiro, M.L., L. Vitiello, M.C.B. Miranda, Y.H.B. Benvengo, A.P.O. Godoy, S. Mendonca, and J. Pedrazolli, Jr. 2003. Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil. Annal. Clinic. Microbiol. Antimicrob. 2, 1-15 DOI |
10 | Simsek, H., Y.H. Balaban, D.D. Gunes, G. Hascelik, E. Ozarslan, and G. Tatar. 2005. Alarming Clarithromycin Resistance of Helicobacter pylori in Turkish Population Helicobacter 10, 360-361 DOI ScienceOn |
11 | Teo, E.K., Fock K.M., T.M. Ng, C.J. Khor, and A.L. Tan. 2000. Metronidazole-resistant Helicobacter pylori in an urban Asian population. J. Gastroenterol. Hepatol. 15, 494-497 DOI ScienceOn |
12 | Uemura, N., S. Okamoto, S. Yamamamoto, N. Matsumura, S. Yamaguchi, M. Yamakido, K. Taniyama, N. Sasaki, and R.J. Schlemper. 2001. Helicobacter pylori infection and the development of gastric cancers. N. England. J. Med. 345, 784-789 DOI ScienceOn |
13 | Van Doorn, L.J., J. Yvette, Y.J. Debets-Ossenkopp, A. Marais, R. Sana, F. Megraud, J.G. Kusters, and W.G.V. Quint. 1999. Rapid detection, by PCR and Reverse Hybridization of Mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob. Agent. Chemother. 43, 1779-1782 |
14 | Van Doorn, L.J., Y. Glupczynski, J.G. Kusters, R. Megraud, P. Midolo, N. Maggi-Soloca, D.M.M. Quiroz, N. Nouhan, E. Stet, and W.G.V. Quint. 2001. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line prob assay for detection of mutations in the 23S rRNA Gene: Multicenter validation study. Antimicrob. Agent. Chemother. 45, 1500-1504 DOI ScienceOn |
15 | Sipponen, P. 1991. Helicobacter pylori and chronic gastritis: an increased risk of peptic ulcer? Scand. J. Gastroenterol. 26, 6-10 |
16 | NIH. 1994. Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. J. Am. Med. Assn. 272, 65-69 DOI |
17 | Khan, R., S. Nahar, J. Sultana, M.M. Ahmad, and R. Motiur. 2004. T2182C Mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob. Agents Chemother. 48, 3567-3569 DOI ScienceOn |
18 | Taylor, D.E., Z. Ge, D. Purych, T. Lo, and K. Hiratsuka. 1997. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents. Chemother. 41, 2621-2628 |
19 | Dzierzanowska-Fangrat, K., E. Rozynek, P. Jozwiak, D. Celinska-Cedro, K. Madalinski, and D. Dzierzanowska. 2001. Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland. In.t J. Antimicrob. Agents 18, 387-390 DOI ScienceOn |
20 | Toracchio, S., G.M. Aceto, R. Mariani-Costantini, P. Battista, and L. Marzio. 2004. Identification of a Novel Mutation Affecting Domain V of the 23S rRNA Gene in Helicobacter pylori. Helicobacter 9, 396-399 DOI ScienceOn |
21 | Marshall, B.J. 1994. Helicobacter pylori. Am. J. Gastroenterol. 89, 116-118 |
22 | Perng, C.L., H.J. Lin, W.C. Lo, G.Y. Tseng, I.C. Sun, and Y.H. Ou. 2004. Genotypes of Helicobacter pylori in patients with peptic ulcer bleeding. World J. Gastroenterol. 10, 602-605 DOI |
23 | Yamaoka, Y., T. Kodama, O. Gutierrez, J.G. Kim, K. Kashima, and D.Y. Graham. 1999. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 37, 2274-2279 |
24 | Eun, C.S., D.S. Han, J.Y. Park, Y.C. Jeon, J.S. Hahm, K.S. Kim, and J.O. Kang. 2003. Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases. Gastroenterol. 38, 436-441 DOI |
25 | Fallone, C.A. 2000. Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. Can. J. Gastroenterol. 14, 879-882 |
26 | Figueiredo, C., L.J. van Doorn, C. Nogueira, J.M. Soares, C. Pinho, P. Figueira, W.G. Quint, and F. Carneiro. 2001. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand. J. Gastroenterol. 36, 128-135 DOI |
27 | Ashour, A.A., G.B. Collares, E.N. Mendes, V.R. Gusmao, D.M. Queiroz, P.P. Magalhaes, A.S. de Carvalho, C.A. de Oliveira, A.M. Nogueira, G.A. Rocha, and A.M. Rocha. 2001. IceA genotypes of Helicobacter pylori strains isolated from Brazilian children and adults. J. Clin. Microbiol. 39, 1746-1750 DOI ScienceOn |
28 | Peek, R.M. Jr, S.A. Thompson, J.P. Donahue, K.T. Tham, J.C. Atherton, M.J. Blaser, and G.G. Miller. 1998. Adherance to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc. Assoc. Am. Physicians. 110, 531- 544 |
29 | Van Doorn, L.J., C. Figueiredo, R. Rossau, G. Jannes, M. van Asbroek, J.C. Sousa, F. Carneiro, W.G. Quint. 1998. Typing of Helicobacter pylori vacA gene, and detection of cagA gene by PCR, and reverse hybridization. J. Clin. Microbiol. 36, 1271-1276 |
30 | Kato, M., Y. Yamaoka, J.J. Kim, R. Reddy, M. Asaka, K. Kashima, M.S. Osato, F.A. El-Zaatari, D.Y. Graham, and D.H. Kwon. 2000. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob. Agents Chemother. 44, 2214-2216 DOI |
31 | Sevin, E., D. Lamarque, J.C. Delchier, C.J. Soussy, and J. Tankovic. 1998. Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR. FEMS Microbiol. Letters 165, 369-372 DOI |
32 | Wu, C.C., P.Y. Chou, C.T. Hu, Z.C. Liu, C.Y. Lin, Y.H. Tseng, and N.T. Lin. 2005. Clinical Relevance of the vacA, iceA, cagA, and flaA genes of Helicobacter pylori strains isolated in Eastern Taiwan. J. Clin. Microbiol. 43, 2913- 2915 DOI ScienceOn |
33 | Ling, T.K.W., W.K. Leung, C.C. Lee, E.K. Ng, M.Y. Yung, M.Y. Chung, S.S. Chung, J.J. Sung, and A.F. Cheng. 2002. The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001). Helicobacter 7, 327-329 DOI ScienceOn |
34 | Nomura, A., G.N. Stemmarman, and P.H. Chyou. 1994. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann. Intern. Med. 120, 977-981 DOI ScienceOn |
35 | Van Doorn, L.J., C. Figueiredo, R. Sanna, A. Plaisier, P. Schneeberger, W. de Boer, and W. Quint. 1998. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115, 58-66 DOI ScienceOn |
36 | Han, Y.H, W.Z. Liu, H.Y. Zhu, and S.D. Xiao. 2004. Clinical relevance of iceA and babA2 genotypes of Helicobacter pylori in a Shanghai population. Chin. J. Dig. Dis. 5, 181-185 DOI ScienceOn |
37 | National Committee for Laboratory Standards. Performance standards for antimicrobial testing. 1999. VI th International supplement. M100S9. National Committee for Clinical Laboratory Standards, Villanova, PA, USA |
38 | Osato, M.S., R. Reddy, S.G. Reddy, R.L. Penland, H.M. Malaty, and D.Y. Graham. 2001. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch. Intern. Med. 161, 1217-1220 DOI ScienceOn |
39 | Sarma, Z., H. Shmuely, Y. Niv, G. Dinari, D.J. Passaro, A. Geler, E. Gal, M. Fishman, J. Bachor, and J. Yahav. 2002. Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J. Antimicrob. Chemother. 49, 1023-1026 DOI ScienceOn |
40 | Fraser, A.G., L. Moore, M. Hackett, and B. Hollis. 1999. Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit. Aust. N. Z. J. Med. 29, 512-516 DOI ScienceOn |
41 | Dubois, A., D.E. Berg, E.T. Incecik, N. Fiala, A.L. Heman, P.G. Perez, and M.J. Blaser. 1996. Transient and persistent experimental infection of non-human primates with Helicobacter pylori: implications for human disease. Infect. Immun. 64, 2885-2891 |
42 | Hirschl, A.M., M. Richter, A. Makristathis, P.M. Pruckl, B. Willinger, K. Schutze, and M.L. Rotter. 1994. Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: Detection by macrorestriction DNA analysis. J. Inf. Dis. 170, 829-33 |
43 | Inan, A., S. Gulsun, H. Guveli, J. Tascioglu, and P. Goktas. 2005. An investigation of Helicobacter pylori using culture, histopathological and serological examination methods and its antimicrobial sensitivities. Saudi. Med. J. 26, 597-600 |
44 | Solerman, A., A. Perren, S. Schmid, F. Eigenmann, R. Guller, K.B. Weher, F. Meier, P. Eichenberger, and P. Komminoth. 2005. Assesment of Helicobacter pylori clarihromycin resistance mutations in archival gastric biopsy samples. Swiss. Med. Wkly. 135, 327-332 |
45 | Kidd, M., R.M. Peek, A.J. Lastovica, D.A. Israel, A.F. Kummer, and J.A. Louw. 2001. Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease. Gut 49, 629-635 DOI |
46 | Loivukene, K., H. Kolk, H.I. Maaroos, P. Kasenomm, M. Ustav, and M. Mikelsaar. 2000. Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia. Scand. J. Infect. Dis. 32, 59-62 DOI |
47 | Mohammadi, M., D. Doroud, S. Massarrat, and M.J. Farahvash. 2003. Clarithromycin resistance in Iranian H. pylori strains before introduction of clarithromycin. Helicobacter 8, 79-80 |
48 | Alarcon, T., D. Domingo, and M. Lopez-Brea. 1999. Antibiotic resistance problems with Helicobacter pylori. Inter. J. Antimicro. Agents 1, 19-26 |
49 | Kim, J.J., R. Reddy, M. Lee, J.G. Kim, F.A. El-Zaatari, M.S. Osato, D.Y. Graham, and D.H. Kwon. 2001. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J. Antimicrob. Chemother. 47, 459-461 DOI ScienceOn |
50 | Megraud, F. 2003. Surveillance de la resistance de Helicobacter pylori aux antibiotiques, p. 327-329. In Surveillance nationale des maladies infectieuses, 1998-2000. Institut de Veille Sanitaire, St. Maurice, France |
51 | Lee, A. and F. Megraud. 1996. Helicobacter pylori: Techniques for clinical diagnosis and basic research, p. 122-123. In J. Hua, C. Birac, and F. Megraud. PCR-based RAPD 'fingerprinting' of clinical isolates of Helicobacter pylori, 2nd ed. Saunders Company Ltd, London, UK |
52 | Sahin, F., A. Ozden, E. Unver, H. Ozenci, O. Uzunalimoglu, G. Atalay, and O. Koc. 1994. Detecting the resistance by agar dilution method for metronidazole and disc diffusion method for amoxycilline and clarithromycin in Helicobacter pylori isolates. Gastroenterology 5, 203-206 |
53 | Fontana, C., M. Favaro, S. Minelli, A.A. Criscuolo, A. Peitro Yusti, A. Galante, and C. Favalli. 2002. New site of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicro. Agents Chemother. 46, 3765-3769 DOI |
54 | Godoy, A.P.O., M.L. Ribeiro, Y.H.B. Benvengo, L. Vitiello, M.C.B. Miranda, S. Mendonca, and J. Pedrazolli, Jr. 2003. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenter. 3, 20-26 DOI ScienceOn |
55 | Perez Aldana, L., M. Kato, S. Nakagawa, M. Kawarasaki, T. Nagasako, T. Mizushima, H. Oda, J. Kodaira, Y. Shimizu, Y. Komatsu, R. Zheng, H. Takeda, T. Sugiyama, and M. Asaka. 2002. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 7, 306-309 DOI ScienceOn |
56 | Soltesz, V., B. Zeeberg, and T. Wadstrom. 1992. Optimal survival of Helicobacter pylori under various transport conditions. J. Clin. Microbiol. 30, 1453-1456 |
57 | Damaso, D., T. Alarcon, N. Prieto, and M. Lopez-Brea. 1999. Relationship between antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. Rev. Esp. Quimioter. 12, 340-345 |
58 | Laine, L., M.B. Fennerty, M. Osato, J. Sugg, L. Suchower, P. Probst, and J.G. Levine. 2000. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicentre, double-blind trials. Am. J. Gastroenterol. 95, 3393-3398 DOI |
59 | Guliter, S., H. Keles, Z.N. Ozkurt, D.U. Cengiz, and E. Kolukisa. 2005. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of Helicobacter pylori? Turk. J. Gastroenterol. 16, 29-33 |
60 | Nishiya, D., T. Shimoyama, S. Fukuda, T. Yoshimura, M. Tanaka, and A. Munakata. 2000. Evaluation of the clinical relevance of the iceA1 gene in patients with Helicobacter pylori infection in Japan. Scand. J. Gastroenterol. 35, 36-39 DOI |
61 | Pounder, R.E. 1997. New developments in Helicobacter pylori eradication therapy. Scand. J. Gastroenterol. Suppl. 223, 43-45 |
62 | Versalovic, J., D. Shortridge, K. Kibler, M.V. Griffy, J. Beyer, R.K. Flamm, S.K. Tanaka, D.Y. Graham, and M.F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents. Chemother. 40, 477-480 |
63 | Glupczynski, Y., F. Megraud, M. Lopez-Brea, and L.P. Andersen. 2001. European multicenter survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 11, 820-823 |
64 | Graham, D.Y., G.M. Lew, P.D. Klein, D.G. Evans, D.J. Evans, Jr., Z.A. Saeed, and H.M. Malaty. 1992. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann. Intern. Med. 116, 705-708 DOI ScienceOn |
65 | Jorgensen, M., G. Daskalopoulus, V. Warburton, H.M. Mitchell, and S.L. Hazell. 1996. Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential and multiple biopsy specimens. J. Infect. Dis. 174, 631-635 DOI ScienceOn |
66 | Laine, L., R. Hunt, H. El-Zimaity, B. Nguyen, M. Osato, and J. Spenard. 2003. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicentre, North American trial. Am. J. Gastroenterol. 98, 562-567 DOI |
67 | World Health Organization. 1994. IARC monographs on the evaluation of carcinogenic risks to human, Geneva. World Health Organization 61, 177-240 |
![]() |